Jewett Amy, Peterson Alexis B, Sauber-Schatz Erin K
a Division of Unintentional Injury Prevention , National Center for Injury Prevention and Control, Centers for Disease Control and Prevention , Atlanta , Georgia.
b Epidemic Intelligence Service, Centers for Disease Control and Prevention , Atlanta , Georgia.
Traffic Inj Prev. 2018;19(7):693-700. doi: 10.1080/15389588.2018.1479525. Epub 2018 Nov 9.
Alcohol- or drug-impaired driving can cause motor vehicle crashes, injuries, and death. Estimates of drug-impaired driving are difficult to obtain. This study explores self-reported prevalence of and factors associated with alcohol, marijuana, and prescription opioid use and impaired driving among adults aged 21 years and older in the United States.
Self-reported data from 3,383 adults in the 2015 Fall ConsumerStyles survey were analyzed. Respondents were asked about alcohol, marijuana, and prescription opioid use and driving while impaired in the last 30 days. Weighted prevalence estimates were calculated. Prevalence ratios and Poisson log-linear regressions were used to identify factors associated with substance use and impaired driving.
Alcohol use was reported by 49.5% (n = 1,676) of respondents; of these, 4.9% (n = 82) reported alcohol-impaired driving. Marijuana use was reported by 5.5% (n = 187) of respondents; of these, 31.6% (n = 59) reported marijuana-impaired driving. Prescription opioid use was reported by 8.8% (n = 298) of respondents; of these, 3.4% (n = 10) reported prescription opioid-impaired driving. Polysubstance use of alcohol and marijuana (concurrent use) was reported by 2.7% (n = 93) of respondents. Among those, 10.8% (n = 10) reported driving impaired by both alcohol and marijuana.
Impaired driving was self-reported among alcohol, marijuana, and prescription opioid users. This article demonstrates the need for more robust alcohol- and drug-related data collection, reporting, and analyses, as well as the emerging need for surveillance of marijuana and prescription opioid-impaired driving. States can consider using proven strategies to prevent impaired driving and evaluate promising practices.
酒后或药后驾驶会导致机动车撞车、人员伤亡和死亡。药后驾驶的估计数据难以获取。本研究探讨了美国21岁及以上成年人自我报告的酒精、大麻、处方阿片类药物使用情况以及与酒后驾驶相关的因素。
对2015年秋季消费者风格调查中3383名成年人的自我报告数据进行了分析。询问了受访者在过去30天内酒精、大麻、处方阿片类药物的使用情况以及酒后驾驶情况。计算了加权患病率估计值。患病率比值和泊松对数线性回归用于确定与物质使用和酒后驾驶相关的因素。
49.5%(n = 1676)的受访者报告有饮酒行为;其中,4.9%(n = 82)报告有酒后驾驶行为。5.5%(n = 187)的受访者报告有大麻使用行为;其中,31.6%(n = 59)报告有药后驾驶行为。8.8%(n = 应为298)的受访者报告有处方阿片类药物使用行为;其中,3.4%(n = 10)报告有药后驾驶行为。2.7%(n = 93)的受访者报告有酒精和大麻的多物质使用(同时使用)情况。在这些人中,10.8%(n = 10)报告有酒精和大麻共同导致的驾驶能力受损。
酒精、大麻和处方阿片类药物使用者中存在自我报告的驾驶能力受损情况。本文表明需要更有力地收集、报告和分析与酒精和药物相关的数据,以及对大麻和处方阿片类药物导致的驾驶能力受损情况进行监测的新需求。各州可考虑采用行之有效的策略来预防驾驶能力受损,并评估有前景的做法。 (注:原文中“8.8% (n = 应为298)”疑似有误,根据计算应为298,已按正确数据翻译)